DK1615626T3 - Tablet med farvet kerne - Google Patents

Tablet med farvet kerne

Info

Publication number
DK1615626T3
DK1615626T3 DK04729172.9T DK04729172T DK1615626T3 DK 1615626 T3 DK1615626 T3 DK 1615626T3 DK 04729172 T DK04729172 T DK 04729172T DK 1615626 T3 DK1615626 T3 DK 1615626T3
Authority
DK
Denmark
Prior art keywords
core
coating
core tablet
colored core
colouring agent
Prior art date
Application number
DK04729172.9T
Other languages
English (en)
Inventor
Guy Vergnault
Pascal Grenier
Christophe Dragan
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of DK1615626T3 publication Critical patent/DK1615626T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
DK04729172.9T 2003-04-24 2004-04-23 Tablet med farvet kerne DK1615626T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309343 2003-04-24
PCT/IB2004/001702 WO2004093850A1 (en) 2003-04-24 2004-04-23 Tablet with coloured core

Publications (1)

Publication Number Publication Date
DK1615626T3 true DK1615626T3 (da) 2010-02-08

Family

ID=33306520

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04729172.9T DK1615626T3 (da) 2003-04-24 2004-04-23 Tablet med farvet kerne

Country Status (9)

Country Link
US (1) US20070148229A1 (da)
EP (1) EP1615626B1 (da)
JP (1) JP4908200B2 (da)
AT (1) ATE445393T1 (da)
CY (1) CY1109726T1 (da)
DE (1) DE602004023597D1 (da)
DK (1) DK1615626T3 (da)
ES (1) ES2335008T3 (da)
WO (1) WO2004093850A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004231362B2 (en) 2003-04-24 2009-11-12 Jagotec Ag Delayed release tablet with defined core geometry
CN103040773A (zh) * 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
WO2006027266A1 (en) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tablets with site time-controlled gastrointestinal release of active ingredient
ES2400446T5 (es) 2006-08-03 2017-03-13 Horizon Pharma Ag Tratamiento con glucocorticoides de liberación retardada de una enfermedad reumática
EP2391369A1 (en) * 2009-01-26 2011-12-07 Nitec Pharma AG Delayed-release glucocorticoid treatment of asthma
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
DK2851075T3 (da) * 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB874586A (en) * 1957-10-28 1961-08-10 Upjohn Co Improvements in or relating to therapeutic compositions and the manufacture thereof
GB860708A (en) * 1958-06-23 1961-02-08 Sterling Drug Inc Medicinal tablets comprising 4-aminoquinoline-type drugs and salicylates
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
BE629982A (da) * 1962-04-06
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5047246A (en) 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
DE3930770A1 (de) * 1989-09-14 1991-03-28 Wolfgang F Dr Schoener Implantierbare katheter aus medizinisch vertraeglichem elastischen kunststoff
US5310578A (en) * 1990-09-17 1994-05-10 Merck Patent Gesellschaft Deposition of cosmetically functional material onto pigments and fillers
DE4100920A1 (de) * 1991-01-15 1992-07-16 Degussa Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
JPH0672861A (ja) * 1992-07-09 1994-03-15 Takeda Chem Ind Ltd 着色固形製剤
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
WO1994008589A1 (en) * 1992-10-09 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Treatment of systemic lupus erythematosus with dehydroepiandrosterone
TW272942B (da) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd
JPH06256171A (ja) * 1993-03-04 1994-09-13 Shin Etsu Chem Co Ltd セルロース系腸溶性コーチング剤
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
US5709880A (en) * 1995-07-10 1998-01-20 Buckman Laboratories International, Inc. Method of making tabletized ionene polymers
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US5792476A (en) * 1996-12-19 1998-08-11 Abigo Medical Ab Sustained release glucocorticoid pharmaceutical composition
US6365185B1 (en) * 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
GB9905898D0 (en) * 1999-03-15 1999-05-05 Darwin Discovery Ltd Controlled-dose formulation
JP2001017121A (ja) * 1999-07-05 2001-01-23 Anpureenu Europe:Kk 被覆粒体及びその製造方法
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
US6720327B2 (en) * 2000-09-27 2004-04-13 Pharmacia Corporation Lactone integrin antagonists
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
JP2002212104A (ja) * 2000-11-17 2002-07-31 Takeda Chem Ind Ltd タルク／硫酸バリウム含有製剤
CA2440641A1 (en) * 2001-03-13 2002-09-19 Anand R. Baichwal Chronotherapeutic dosage forms containing glucocorticosteroid
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
IN191028B (da) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US20040213848A1 (en) * 2001-09-28 2004-10-28 Shun-Por Li Modified release dosage forms
JP4336074B2 (ja) * 2001-11-15 2009-09-30 三菱商事フードテック株式会社 色調および食感が良好な硬質糖衣錠剤
AU2004231362B2 (en) * 2003-04-24 2009-11-12 Jagotec Ag Delayed release tablet with defined core geometry
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum

Also Published As

Publication number Publication date
EP1615626B1 (en) 2009-10-14
JP2006524230A (ja) 2006-10-26
JP4908200B2 (ja) 2012-04-04
US20070148229A1 (en) 2007-06-28
ATE445393T1 (de) 2009-10-15
WO2004093850A1 (en) 2004-11-04
EP1615626A1 (en) 2006-01-18
DE602004023597D1 (de) 2009-11-26
CY1109726T1 (el) 2014-09-10
ES2335008T3 (es) 2010-03-18

Similar Documents

Publication Publication Date Title
CY1109726T1 (el) Δισκιο εγχρωμου πυρηνα
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
AR064901A2 (es) Una pelicula consumible adaptada para disolverse en la boca de un consumidor
BRPI0409623A (pt) produto farmacêutico, método de preparação do mesmo e uso de substáncias na preparação do referido produto farmacêutico
AR021391A1 (es) Inhaladores presurizados de dosis medidas (mdi) y su uso.
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
ES2185817T3 (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de las bombas de protones y un agente antiacido o alginato.
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
TR199701584T1 (xx) Anestezi etkili yeni farmas�tik kompozisyon
UY27186A1 (es) Formulación farmacéutica
ATE430557T1 (de) Liposomen
PT1212317E (pt) Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
AU2003280918A8 (en) Rabbit skin comprising biological active substance and its use
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
ITBO930205A0 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
TR200101970T2 (tr) Solunum yollarì hastalìklarìnìn tedavisinde matriks metaloproteaz inhibit”rleri olarak ikameli 4-biarilbutirik ve 5-biarilpentanoik asit trevlerinin kullanìlmasì
PT994887E (pt) Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao
BR0116972A (pt) Métodos e dispositivos para administração de substâncias na camada intradérmica da pele para absorção sistêmica
BR0104283A (pt) Agente de barreira para um artigo absorvente, e, artigo absorvente